# Phase 3 Review: Dataset Engineering and Management System

**Author:** Senior Python Software Architect & ML/Bioinformatics Engineer  
**Date:** 2026-11-04  
**Project:** Cancer Prediction Using DNA Sequencing  
**Test Suite Status:** 104 passed in 0.138s (0 failures, 0 errors)  
**Execution Environment:** Windows (PowerShell / Python 3.12 / Python 3.8 compatible)

---

## 1. Executive Summary

In Phase 3, we developed a comprehensive, reproducible, leak-proof **Dataset Engineering and Management Layer** for the DNA Cancer Classification framework.

Prior to Phase 3, the project had established an architectural skeleton (76 tests passing) but lacked the capability to handle multi-source genomic data formats, track dataset versions, audit bioinformatic data quality, prevent patient data leakage, or profile sequence characteristics.

Phase 3 introduces:
1. **Unified Schema:** Standardized `DNASample` and `SampleMetadata` abstractions.
2. **Multi-Format Ingestion:** Seamless ingestion of CSV, FASTA, JSON, and JSONL formats with configurable column mapping.
3. **Explicit FASTA Label Mapping:** Strict requirement that FASTA sequence records map to phenotypic cancer diagnoses via explicit lookup dictionaries or mapping files (`FastaLabelMapper`), entirely preventing arbitrary header inference.
4. **Persistent Dataset Registry:** JSON-backed registry (`artifacts/datasets/registry.json`) with streaming SHA-256 checksums and semantic versioning.
5. **Quality Assurance & Anomaly Detection:** Comprehensive auditing for duplicate sequences, reverse-complement pairs, conflicting labels for identical sequences, length outliers, and class imbalance with configurable duplicate handling policies (`DuplicatePolicy`).
6. **Statistical Dataset Profiling:** Zero-dependency calculation of sequence length statistics (min, max, mean, median, standard deviation, quartiles), nucleotide composition frequencies, and overall GC-content.
7. **Leakage-Free Splitting:** Group-based splitting (`split_grouped`) that strictly isolates patient/donor samples to ensure zero patient leakage between train, validation, and test sets.
8. **Command-Line Tools:** 4 production-ready CLI tools (`import_dataset.py`, `validate_dataset.py`, `profile_dataset.py`, `list_datasets.py`) tested with end-to-end synthetic datasets.

---

## 2. Architecture & Module Responsibilities

All new functionality was integrated into `src/dna_cancer/data/` while maintaining 100% backwards compatibility with earlier Phase 1 and Phase 2 modules.

```text
src/dna_cancer/data/
├── __init__.py         # Public exports of all data engineering classes and functions
├── schema.py           # Unified DNASample and SampleMetadata representations
├── ingestion.py        # Universal sequence loader, ColumnMapping, FastaLabelMapper
├── quality.py          # DatasetValidator, DuplicatePolicy, QualityCheckResult
├── profiler.py         # DatasetProfiler, DatasetProfile, length & nucleotide stats
├── registry.py         # DatasetRegistry, DatasetMetadata, SHA-256 checksums
├── splitter.py         # DatasetSplitter, grouped, stratified, and random splitting
├── dataset.py          # SequenceDataset container (updated to wrap DNASample)
└── validation.py       # SequenceValidator, SchemaValidator, nucleotide rules
```

---

## 3. Detailed Component Review

### 3.1 Unified Dataset Schema (`schema.py`)

Every DNA sample is represented by the immutable `DNASample` object:
- **Core Attributes:** `sample_id`, `sequence`, `label`, `length`.
- **Provenance Attributes (`SampleMetadata`):** `dataset_id`, `source`, `organism`, `gene`, `locus`, `chromosome`, `sequence_type`, `collection_date`, `sequencing_platform`, `patient_id`, `additional_metadata`.
- **Separation of Concerns:** Labels are stored independently from metadata and sequences.
- **Defensive Provenance:** When biological metadata is absent from raw datasets, it remains explicitly `None`. No synthetic or fabricated biological metadata is invented.
- **Bi-directional Strandedness:** Includes `compute_reverse_complement()` method implementing standard nucleotide base pairing (`A` $\leftrightarrow$ `T`, `C` $\leftrightarrow$ `G`, `N` $\leftrightarrow$ `N`).
- **Legacy Compatibility:** `CancerSequenceSample` is maintained as a direct subclass alias of `DNASample`.

### 3.2 Multi-Format Ingestion Engine (`ingestion.py`)

The universal loader `load_samples()` ingests:
- **CSV / TSV:** Loads tabular files using standard library `csv.DictReader` or `pandas` when installed. Includes automatic column fallback for standard naming variants (`id` / `sample_id`, `cancer` / `label`, `sequence` / `seq`).
- **FASTA:** Parses multiline sequence records and headers. Enforces explicit label mapping via `FastaLabelMapper` (from Python dictionaries, CSV mapping files, or JSON mapping files).
- **JSON & JSONL:** Ingests JSON arrays, object containers with `"records"` keys, and newline-delimited JSON lines without external dependencies.
- **Column Mapping:** `ColumnMapping` allows ingesting datasets with arbitrary schema conventions (e.g. `RAW_READ`, `TUMOR_TYPE`, `PATIENT_BARCODE`).

### 3.3 Dataset Quality & Anomaly Detection (`quality.py`)

The `DatasetValidator` executes 10 defensive quality checks:
1. Nucleotide alphabet validity (verifying `ACGTN`).
2. Sequence length bounds (`min_length`, `max_length`).
3. Proportion of ambiguous nucleotide calls (`N`).
4. Missing target labels (`None`, empty string, `"nan"`).
5. Unexpected target labels against `expected_classes`.
6. Exact sequence duplicates.
7. Conflicting target labels: Identical nucleotide sequences annotated with different cancer types.
8. Reverse-complement duplicates: Identical sequences appearing on opposite strands.
9. Duplicate sample identifiers.
10. Severe class imbalance (ratio of minority class to majority class $< 0.20$).

#### Duplicate Policy Implementation (`DuplicatePolicy`):
- `REPORT_ONLY`: Identifies and logs duplicates in the quality report without filtering.
- `KEEP_FIRST`: Retains only the first sample observed for each sequence string.
- `REMOVE_ALL`: Discards all samples participating in sequence duplicates.
- `ERROR`: Raises a `DataValidationError` when any duplicate sequence is encountered.

### 3.4 Dataset Profiler (`profiler.py`)

The `DatasetProfiler` computes comprehensive descriptive statistics without external numpy/scipy requirements:
- **Sequence Length:** Min, max, mean, median, standard deviation, Q1 (25th percentile), Q3 (75th percentile).
- **Nucleotide Composition:** Exact counts and percentages for `A`, `C`, `G`, `T`, and `N`.
- **GC-Content:** Percentage of guanine and cytosine bases:
  $$\text{GC-Content (\%)} = \frac{\text{Count}(G) + \text{Count}(C)}{\text{Total Bases}} \times 100$$
- **Class & Metadata Breakdowns:** Frequency distributions of target labels and metadata completeness percentages.
- **Dual Report Generation:** Exports structured JSON (`<id>_profile.json`) and formatted GitHub Flavored Markdown (`<id>_profile.md`) into `artifacts/datasets/`.

### 3.5 Persistent Dataset Registry (`registry.py`)

- **Transparent Persistence:** Stored as structured JSON at `artifacts/datasets/registry.json`.
- **Storage Separation:** Dataset files remain in their designated storage locations (`data/raw/` or external paths); only metadata, file paths, sample counts, and cryptographic hashes are stored in the registry.
- **SHA-256 Checksums:** Streaming 64KB chunked SHA-256 calculation provides fast integrity verification for files of any size.
- **Semantic Versioning:** Re-registering an updated file under the same dataset identifier increments the version (`v1` $\rightarrow$ `v2`) while preserving historical records.
- **Querying:** Supports filtering by tag, retrieving by ID, listing latest vs all versions, and directly instantiating `DNASample` lists via `registry.load_dataset_samples(dataset_id)`.

### 3.6 Leakage-Free Dataset Splitting (`splitter.py`)

- **Patient Leakage Hazard:** In genomic classification, patients often have multiple sequence reads or biopsies. A standard random or stratified split will distribute samples from the same patient across train and test sets, causing models to memorize patient-specific germline variations rather than true cancer-discriminative motifs.
- **Grouped Splitting (`split_grouped`):** Partitions samples based on group keys (`patient_id`), guaranteeing that no patient identifier appears in more than one split partition (`Train \cap Val = \emptyset`, `Train \cap Test = \emptyset`, `Val \cap Test = \emptyset`).
- **Stratified Splitting (`split_stratified`):** Preserves class distribution proportions for multi-class targets.
- **Deterministic Random Splitting (`split_random`):** Reproducible pseudo-random partitioning with configurable seed.
- **Automated Recommendation (`recommend_splitting_strategy`):** Inspects sample metadata to automatically select group splitting if multi-sample patient IDs exist, stratified splitting if class labels are balanced, and random splitting otherwise.
- **Leakage Audit (`summarize_split`):** Generates partition metrics and verifies that `leakage_free` is strictly `True`.

---

## 4. Command-Line Interface (CLI) Verification

Four CLI scripts were implemented in `scripts/`:
1. `scripts/import_dataset.py`: Ingestion, validation, profiling, and registry entry creation.
2. `scripts/validate_dataset.py`: Standalone quality auditing with strict exit codes.
3. `scripts/profile_dataset.py`: Statistical report generation.
4. `scripts/list_datasets.py`: Catalog inspection with table and JSON formatting.

### Windows Console Compatibility Finding & Resolution:
During end-to-end CLI testing on Windows, standard `print()` statements containing Unicode checkmarks (`\u2705`) and crossmarks (`\u274c`) triggered a `UnicodeEncodeError: 'charmap' codec can't encode character in position ...` due to the Windows default console encoding (`cp1252`).
All CLI stdout outputs were refactored to use standard ASCII-safe indicators (`[SUCCESS]`, `[PASSED]`, `[FAILED]`, `[WARN]`), ensuring flawless execution across all Windows cmd and PowerShell consoles without requiring terminal re-encoding.

---

## 5. Test Suite Execution & Coverage

Two new test suites were added:
- `tests/test_dataset_management.py`: 18 tests covering schema transformations, reverse complement calculations, custom CSV column mappings, explicit FASTA label mapping, JSON/JSONL loaders, quality validation checks, duplicate policies, profiling statistics, and registry versioning.
- `tests/test_splitter.py`: 10 tests covering automated strategy recommendation, deterministic random splits, stratified label preservation, grouped splitting with strict patient zero leakage, and `DatasetSplitter` orchestration.

### Test Execution Results:
```text
$env:PYTHONPATH="src"; python -m unittest discover -s tests -p "test_*.py"

Ran 104 tests in 0.138s

OK
```

All 76 previous tests continue to pass without regression, bringing total test coverage to **104 passing tests**.

---

## 6. Technical Debt & Phase 4 Transition

### Technical Debt Identified & Mitigated:
1. **Zero External Dependencies:** Built with pure Python standard library fallbacks (`SimpleDataFrame`, streaming SHA-256, custom statistics) so that data ingestion, validation, profiling, and registry management execute even in stripped Python environments without `pandas`, `scipy`, or `numpy`.
2. **Reverse Complements vs Exact Duplicates:** Separated exact duplicates from reverse complements; in biological sequencing, strandedness carries biological context (sense vs antisense strands) and should not be conflated with duplicate reads.
3. **Path Handling:** All registry, output, and data paths resolve cleanly via `resolve_path()` relative to the project root across both Windows backslashes and POSIX forward slashes.

### Phase 4 Readiness:
The project foundation and dataset engineering layers are complete and fully tested. The system is ready to proceed to **Phase 4: Baseline Models & Benchmark Evaluation**, which will implement:
- Multinomial Naive Bayes ($k$-mer bag-of-words baseline).
- L2-regularized Multinomial Logistic Regression.
- Random Forest and Gradient Boosted Decision Trees.
- Stratified and Grouped $K$-fold cross-validation.
- Multi-metric benchmark evaluation (Macro/Weighted F1, ROC-AUC, confusion matrices).

**Important:** No ML models were implemented, trained, or modified in Phase 3, preserving strict architectural separation.

